Cotreatment with 17-allylamino-demethoxygeldanamycin and FLT-3 kinase inhibitor PKC412 is highly effective against human acute myelogenous leukemia cells with mutant FLT-3.

Source:http://linkedlifedata.com/resource/pubmed/id/15150124

Cancer Res. 2004 May 15 64 10 3645-52

Download in:

View as

Triples

General Info

PMID
15150124